Protocol 10553, "A Phase 2 Study of Darolutamide in Combination with Leuprolide Acetate in Hormone-Therapy Naive Recurrent and/or Metastatic Androgen Receptor (AR) Positive Salivary Gland Cancer,"
University of Colorado Hospital
Daniel Bowles, MD
Protocol Number: 23-0845
More information available at ClinicalTrials.gov: NCT05669664
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers